Idarubicin Hydrochloride (Teva Parenteral Medicines, Inc.)
Welcome to the PulseAid listing for the Idarubicin Hydrochloride drug offered from Teva Parenteral Medicines, Inc.. This Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [Chemical/Ingredient],Topoisomerase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Teva Parenteral Medicines, Inc. |
NON-PROPRIETARY NAME: | Idarubicin Hydrochloride |
SUBSTANCE NAME: | IDARUBICIN HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [Chemical/Ingredient],Topoisomerase Inhibitors [MoA] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2002-10-01 |
END MARKETING DATE: | 0000-00-00 |
Idarubicin Hydrochloride HUMAN PRESCRIPTION DRUG Details:
Item Description | Idarubicin Hydrochloride from Teva Parenteral Medicines, Inc. |
LABELER NAME: | Teva Parenteral Medicines, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 1(mg/mL) |
START MARKETING DATE: | 2002-10-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0703-4154_903278ff-4613-4b29-9b22-97bbe312ecbd |
PRODUCT NDC: | 0703-4154 |
APPLICATION NUMBER: | ANDA065036 |
Other IDARUBICIN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: